|

Lupus strikes as many as 2 million Americans—and
15 million people worldwide
When the immune system loses the ability to distinguish between
dangerous interlopers—like viruses, bacteria and fungi—and its own cells, the body’s
defense mechanisms become weapons of self-destruction. The resulting barrage of friendly
fire can cause more than 80 different diseases. Chief among them is lupus, and OMRF has
emerged a world leader in the study and treatment of this life-threatening illness.
OMRF’s Dr. John Harley spearheads an international consortium that has
identified 13 genes specifically associated with the disease. The massive research
project, which involves 150 scientists and 7,000 research volunteers, has opened new
frontiers in the quest to unmask the genetic culprits behind the disease.
Meanwhile, Dr. Judith James has made a series of key findings that
point to a common cold virus as a potential environmental trigger for lupus. Her work
now is moving toward developing a vaccine that could one day prevent the onset of the
virus—and lupus.
In OMRF’s rheumatology clinic, physician-scientists provide sick
Oklahomans with access to experimental lupus treatments not yet widely available. If any
of these novel therapeutics proves effective, OMRF will have played a key role in
delivering the first new lupus drug to patients in nearly a half-century.
|